Gender differences in outcomes of cancer patients with COVID-19
Bishal Gyawali, MD, PhD, Queen’s University, Kingston, ON, Canada, discusses the key findings from his recent paper that looked at the gender differences in …
Bishal Gyawali, MD, PhD, Queen’s University, Kingston, ON, Canada, discusses the key findings from his recent paper that looked at the gender differences in …
CADTH Lecture Series #1 Fall 2019There is a big difference between being hopeful and creating hype around various Cancer drugs and treatments. We need to…
This is the recording of a lecture delivered to the National Breast Cancer Coalition (NBCC), a patient advocacy group focused on empowering patients with bre…
This is the recording of a lecture delivered to the National Breast Cancer Coalition (NBCC), a patient advocacy group focused on empowering patients with bre…
This is the recording of a lecture delivered to the National Breast Cancer Coalition (NBCC), a patient advocacy group focused on empowering patients with bre…
#surrogate #endpoints #clinicaltrials #cancer #oncology
#surrogate #endpoints #clinicaltrials #cancer #oncology
#communicationskills#breakingbadnews#cancer#oncology
This study examines the strength of association between surrogate markers used as primary end points in clinical trials to support FDA approval of drugs treating…